Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
companyunderground
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
»
companies
» Neurocrine Biosciences
Neurocrine Biosciences
Neurocrine signs $400M-plus deal with Idorsia for epilepsy drug
Pharmaforum
Fri, 01/10/20 - 10:23 am
Idorsia
Neurocrine Biosciences
epilepsy
pediatric epilepsy
ACT-709478
Why Earnings Season Could Be Great for Neurocrine Biosciences (NBIX)
Yahoo/Zacks.com
Sat, 11/2/19 - 07:49 pm
Neurocrine Biosciences
earnings
Neurocrine Biosciences Posts Sizzling Sales Growth in Q2
Motley Fool
Tue, 07/30/19 - 07:58 am
Neurocrine Biosciences
earnings
FDA Accepts Neurocrine's NDA for Parkinson's Disease Drug
Yahoo/Zacks.com
Fri, 07/12/19 - 09:45 am
Neurocrine Biosciences
FDA
Parkinson's Disease
opicapone
Neurocrine’s Opicapone Plus Levodopa Improves Parkinson’s Symptoms
BioSpace
Mon, 05/6/19 - 10:59 am
Neurocrine Biosciences
clinical trials
opicapone
Parkinson's Disease
2 Biotech Takeout Targets Perfect for Biogen
Motley Fool
Sat, 03/23/19 - 12:11 pm
Biogen
M&A
SAGE Therapeutics
Neurocrine Biosciences
Neurocrine, Jnana team up to discover CNS drugs
Fierce Biotech
Wed, 10/10/18 - 10:17 am
Neurocrine Biosciences
Jnana Therapeutics
small molecule drugs
CNS
drug discovery
From near non-existence to major biotech star: Neurocrine's journey
San Diego Tribune, CA
Sun, 08/26/18 - 07:13 pm
Neurocrine Biosciences
3 Biotech Stocks With Major Potential Catalysts in July
Yahoo/Motley Fool
Wed, 06/27/18 - 09:45 am
Neurocrine Biosciences
AbbVie
Progenics
INSYS Therapeutics
Elagolix
endometriosis
Azedra
adrenal tumors
Syndros
3 Biotechs That Could Get Big Boosts in April
Motley Fool
Wed, 03/28/18 - 10:02 am
biotech
GW Pharma
Epidiolex
Incyte
olumiant
baricitinib
Neurocrine Biosciences
Elagolix
3 Big Biotech Stocks With Major Catalysts on the Way
Motley Fool
Tue, 01/30/18 - 09:50 am
biotech
AbbVie
Neurocrine Biosciences
Elagolix
Celgene
ozanimod
Gilead Sciences
bictegravir
Neurocrine Poised To Corner Tardive Dyskinesia Market With Ingrezza
Seeking Alpha
Tue, 07/11/17 - 09:36 am
Neurocrine Biosciences
Ingrezza
tardive dyskinesia
Elagolix
uterine fibroids
Why Valbenazine Studies Seem Promising
Market Realist
Fri, 12/2/16 - 10:49 am
valbenazine
tardive dyskinesia
Neurocrine Biosciences
Elagolix May Become a Leading Uterine Fibroids Drug
Market Realist
Tue, 11/29/16 - 05:35 pm
uterine fibroids
Elagolix
AbbVie
Neurocrine Biosciences
8 Speculative Biotech and Biohealth Stocks With Major Analyst Upside Calls
24/7 Wall St
Mon, 05/30/16 - 10:05 am
GW Pharma
Integra LifeSciences
Minerva Neurosciences
Neurocrine Biosciences
Teladoc
TG Therapeutics
Asterias
Innocoll GmbH
9 Biotech Picks for 2016
Barron's
Sat, 01/2/16 - 10:19 am
biotech
Adaptimmune
Dermira
FibroGen
Incyte
Intra-Cellular Therapies
Seres Therapeutics
Ophthotech
Neurocrine Biosciences
Paratek
Neurocrine Biosciences Starts A Data-Rich Year On The Right Foot
Seeking Alpha
Fri, 01/9/15 - 07:02 pm
Neurocrine Biosciences
AbbVie
Elagolix
What Investors Expect From Neurocrine Biosciences' Next Drug Announcement
Yahoo/Benzinga
Fri, 01/2/15 - 07:29 pm
Neurocrine Biosciences
AbbVie
endometriosis
Elagolix
2015 Biotech Drug/Stock Outlook: Here's What You Need to Know
TheStreet.com
Wed, 12/17/14 - 10:02 am
Biogen Idec
Bluebird Bio
Arrowhead Research
Vertex Pharmaceuticals
Cempra
CTI BioPharma
Gilead Sciences
Merck
Bristol-Myers Squibb
Sarepta Therapeutics
Neurocrine Biosciences
Neurocrine Biosciences Looking Forward To A Big Year
Seeking Alpha
Thu, 11/6/14 - 02:57 pm
Neurocrine Biosciences
Pages
« first
‹ previous
1
2
3
4
next ›
last »